BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38255996)

  • 1. Expression Pattern and Prognostic Significance of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 in Chronic Lymphocytic Leukemia.
    Tomic Vujovic K; Ugrin M; Tosic N; Vukovic V; Marjanovic I; Kostic T; Stankovic S; Otasevic V; Sarac S; Antic D; Pavlovic S; Karan-Djurasevic T
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of BCL11A in chronic lymphocytic leukaemia.
    Tosic N; Ugrin M; Marjanovic I; Kostic T; Vukovic V; Tomic K; Otasevic V; Antic D; Mihaljevic B; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2023 Feb; 45(1):64-71. PubMed ID: 36120992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia.
    Karousi P; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A; Kontos CK
    Clin Biochem; 2020 Nov; 85():20-26. PubMed ID: 32745483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CRNDE is downregulated and associated with poor prognostic markers in chronic lymphocytic leukemia.
    Shehata AMF; Gohar SF; Muharram NM; Soliman SS; Shalaby HM; Kamal Eldin SM; El-Bassal FI
    Int J Lab Hematol; 2024 Feb; 46(1):107-112. PubMed ID: 37814899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms.
    Fernández-Garnacho EM; Nadeu F; Martín S; Mozas P; Rivero A; Delgado J; Giné E; López-Guillermo A; Duran-Ferrer M; Salaverria I; López C; Beà S; Demajo S; Jares P; Puente XS; Martín-Subero JI; Campo E; Hernández L
    Sci Rep; 2023 Oct; 13(1):16839. PubMed ID: 37803049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of
    Ahmadi A; Kaviani S; Yaghmaie M; Pashaiefar H; Ahmadvand M; Jalili M; Alimoghaddam K; Eslamijouybari M; Ghavamzadeh A
    Blood Res; 2018 Dec; 53(4):320-324. PubMed ID: 30588470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
    Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
    J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
    Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
    Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterase 7B mRNA: an unfavorable characteristic in chronic lymphocytic leukemia.
    Zhang L; Murray F; Rassenti LZ; Pu M; Kelly C; Kanter JR; Greaves A; Messer K; Kipps TJ; Insel PA
    Int J Cancer; 2011 Sep; 129(5):1162-9. PubMed ID: 21120911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
    Baumann T; Delgado J; Santacruz R; Martínez-Trillos A; Rozman M; Aymerich M; López C; Costa D; Carrió A; Villamor N; Montserrat E
    Br J Haematol; 2016 Jan; 172(1):48-55. PubMed ID: 26559905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
    Cho SF; Chang YC; Chang CS; Lin SF; Liu YC; Hsiao HH; Chang JG; Liu TC
    BMC Cancer; 2014 Nov; 14():809. PubMed ID: 25369863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients.
    Khalifa MM; Zaki NE; Nazier AA; Moussa MA; Haleem RA; Rabie MA; Mansour AR
    J Egypt Natl Canc Inst; 2021 Dec; 33(1):37. PubMed ID: 34866170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
    Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
    Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
    Abo Elwafa R; Abd Elrahman A; Ghallab O
    Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
    Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
    Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.
    Xu W; Li JY; Wu YJ; Yu H; Shen QD; Tian T; Li L; Qiu HX
    Leuk Res; 2009 Feb; 33(2):237-43. PubMed ID: 18674817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of long non-coding RNA
    Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
    Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
    Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
    Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGHV3-21 gene expression in patients with B-cell chronic lymphocytic leukemia in Ukraine.
    Abramenko I; Bilous N; Kryachok I; Filonenko I; Pilipenko G; Chumak A; Bazyka D; Bebeshko V
    Exp Oncol; 2007 Sep; 29(3):226-30. PubMed ID: 18004251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.